论文部分内容阅读
进入今年下半年,随着市场的调整,医药股开始成为市场避险资金的香饽饽。而医药主题基金也沾光受益,新基金也想搭上这趟顺风车,而敏感的投资者更会蜂拥而上。医药主题基金作为市场资金的避风港,一直以来都颇受关注。而今年,在多重利好的形势下,医药主题基金今年优势更加明显,使得医药主题基金再次成为基金热点。业绩突飞猛进医药主题基金一直以来就备受关注,今年更是突出。自10月之后,医药主题基金就开始表现出不俗的成绩。在整个公募基金中,医药主题基金业绩都有较好的排名。
Into the second half of this year, with the adjustment of the market, pharmaceutical stocks began to become the market hedge funds. Themed funds have also benefited from the project, the new fund also want to catch this ride along the way, and more sensitive investors will rush. As the safe haven for market funds, themed medicine funds have always been of great concern. This year, under the positive and favorable conditions, the pharmaceutical theme fund has even more obvious advantages this year, making themed medicine funds once again become hot spots for the fund. Achievements by leaps and bounds Medicine theme fund has been the concern, this year is even more prominent. Since October, themed funds have started to show good results. In the entire raised funds, pharmaceutical theme fund performance has a better ranking.